Theriva Biologics Inc.
13F holders, Q2 2024 (June 30)22holders −2
2new positions
4sold out
1famous investor
$0.24avg. 13F price*
At the end of Q2 2024, 22 institutions reported holding Theriva Biologics Inc. in their 13F filings, down 2 from Q1 2024. 2 opened new positions and 4 sold out. The largest holders were MSD Partners, L.P. ($141K), Vanguard Group Inc. ($46K) and BlackRock Inc. ($45K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U409
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $141K |
| Exits | 4 | $1.0M |
All 13F filers, Q1 2024 → Q2 2024: 685,101 shares bought and 90,706 shares sold, net +594,395 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| MSD Partners, L.P. | 0.01% | New | 598,411 | $141K |
| Vanguard Group Inc. | 0.00% | Reduce -13.7% | 194,494 | $46K |
| BlackRock Inc. | 0.00% | No change | 189,181 | $45K |
| Geode Capital Management, LLC | 0.00% | No change | 141,168 | $33K |
| Renaissance Technologies | 0.00% | Add +51.4% | 103,710 | $25K |
| Two Sigma Securities, LLC | 0.00% | Add +186.9% | 61,023 | $14K |
| State Street Corp. | 0.00% | No change | 48,691 | $12K |
| Northern Trust Corp. | 0.00% | Reduce -0.5% | 26,477 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +23404.3% | 11,047 | $3K |
| Blair William & Co. | 0.00% | No change | 10,153 | $2K |
| FMR LLC | 0.00% | Add +4900.0% | 500 | $118 |
| Iron Horse Wealth Management, LLC | 0.00% | No change | 365 | $86 |
| IFP Advisors, Inc | 0.00% | No change | 296 | $70 |
| Bank of America Corp. | 0.00% | Add +2333.3% | 146 | $34 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 145 | $34 |
| Planning Capital Management Corp | 0.00% | New | 110 | $26 |
| Wells Fargo & Company | 0.00% | Reduce -57.1% | 100 | $24 |
| Towne Trust Company, N.A | 0.00% | No change | 100 | $24 |
| Morgan Stanley | 0.00% | No change | 15 | $4 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 14 | $3 |
| UBS Group AG | 0.00% | No change | 3 | $1 |
| Royal Bank of Canada | 0.00% | No change | 9 | $0 |
"% of holder's portfolio" is THERIVA BIOLOGICS INC's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.